MANILA, Philippines — The China-made Sinovac vaccine is suitable for those in the regular workforce, like construction workers and drivers, the Food and Drug Administration (FDA) said Tuesday.
Although it gave Sinovac’s vaccine an emergency use authorization, FDA did not recommend it to be administered on health workers treating Covid-19 patients and senior citizens, two risk groups which both have the highest chance of contracting the virus.
With the regular workforce, FDA said Sinovac has a 65 to 91 percent efficacy rate, as compared to exposed health workers and seniors, who will only get 50.4-percent protection from the vaccine.
“Lalo na po yung 18 to 59 [years old] na…
Keep on reading: Sinovac suitable for workforce not always exposed to coronavirus — FDA